CDH2 and neoplasm: In addition, the outcomes of immunohistochemical experiment displayed that the positivity of oncogenic Ki-67, PCNA and N-cadherin was declined while that of tumor-suppressive E-cadherin was enhanced in tumors with the interference of LINC01559 (Fig. 2F).